The Effect of Graded Motor Imagery on Pain and Function in Individuals With Knee Osteoarthritis
Launched by ARTVIN CORUH UNIVERSITY · Jun 22, 2023
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
46 voluntary patients with knee OA, aged between 45-64 years will be randomly divided into two groups: GMI group and TENS group. Interventions will be applied for 8 weeks, 3 times a week (24 sessions). Both groups will receive conventional physiotherapy and home exercises in addition to GMI or TENS treatment. The patients will be assessed before, after treatment and six-week follow-up. Knee pain will be evaluated using the Visual Analog Scale (VAS), pressure pain threshold will be measured using an algometer, pain, function, and stiffness will be assessed using the Western Ontario and McMas...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Minimum score of 24 on the Mini Mental State Examination (indicating no mild or severe dementia)
- • Diagnosis of moderate unilateral knee osteoarthritis persisting for more than 12 months according to American College of Rheumatology (ACR) criteria
- • Experience of pain with a severity rating of 3 or higher on the Visual Analog Scale (VAS) for activities such as stair climbing, sitting, and squatting, lasting for at least 6 months (moderate to severe pain)
- • Age between 45 and 64 years
- • Residing in the city where the study is conducted
- • Ability to walk independently
- • Presence of limitations in knee range of motion (ROM)
- • Symptomatic and radiographically confirmed OA diagnosis of Kellgren and Lawrence grade I-III
- Exclusion Criteria:
- • Patients who are unwilling to participate in the study
- • Patients presenting with secondary OA due to conditions such as rheumatoid arthritis, gout, septic arthritis, tuberculosis, tumor, trauma, hemophilia, major medical or psychiatric disorders, recent fractures, presence of effusion or open reduction and internal fixation in the knee
- • Presence of a neuromuscular disease
- • History of intra-articular injections in the past 6 months
- • Patients undergoing medication changes
- • Presence of any chronic illness that would hinder participation in the treatment program
- • Participation in a physiotherapy program for OA in the last 12 weeks
- • Movement limitations or limb deficiency in the contralateral lower extremity
- • Presence of visual or hearing problems that would affect treatment adherence.
About Artvin Coruh University
Artvin Coruh University is a distinguished educational and research institution located in Turkey, dedicated to advancing knowledge and innovation in various fields, including healthcare and clinical research. The university actively engages in clinical trials aimed at enhancing medical practices and improving patient outcomes. With a commitment to ethical standards and scientific rigor, Artvin Coruh University collaborates with multidisciplinary teams to conduct impactful research that contributes to the advancement of medical science and the well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Artvin, , Turkey
Patients applied
Trial Officials
Zeynep Yıldız Kızkın, PhD
Principal Investigator
Artvin Coruh University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported